Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression
about
P1343
Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNADistribution of candidate genes for experimentally induced arthritis in ratsHeterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.Activity-dependent regulation of MHC class I expression in the developing primary visual cortex of the common marmoset monkey.Assumptions of the tumor 'escape' hypothesis.Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene.Cancer vaccines: progress reveals new complexities.Stromal cells from human decidua exert a strong inhibitory effect on NK cell function and dendritic cell differentiation.NAC, tiron and trolox impair survival of cell cultures containing glioblastoma tumorigenic initiating cells by inhibition of cell cycle progression.Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumorsFalse homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia.Viral and non-viral vectors in gene therapy: technology development and clinical trials.Loss of human leucocyte antigen class I and gain of class II expression are early events in carcinogenesis: clues from a study of Barrett's oesophagus.Decoding the Structural Bases of D76N ß2-Microglobulin High Amyloidogenicity through Crystallography and Asn-Scan Mutagenesis.Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains.Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system.Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.Calnexin retains unassembled major histocompatibility complex class I free heavy chains in the endoplasmic reticulum.An unstable beta 2-microglobulin: major histocompatibility complex class I heavy chain intermediate dissociates from calnexin and then is stabilized by binding peptide.TAP-independent, beta 2-microglobulin-dependent surface expression of functional mouse CD1.1.Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapyLoss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapyQuantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors.Biosynthesis of HLA-C heavy chains in melanoma cells with multiple defects in the expression of HLA-A, -B, -C molecules.Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas.Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?Identification and characterization of an alternatively spliced variant of the MHC class I-related porcine neonatal Fc receptor for IgGAnti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.Defective major histocompatibility complex class I expression in a sarcomatoid renal cell carcinoma cell line.Locus-specific analysis of human leukocyte antigen class I expression in melanoma cell linesHLA associations in the antitumor response against malignant melanoma.Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma.Photoaffinity antigens for human gammadelta T cells.
P2860
Q24601273-F871B0E6-E3DE-49C5-83D3-94D99D4B5B00Q33536127-02689974-4EEC-412F-B376-793AB121F264Q33827463-C4FE1861-6747-42EC-8E8F-222E408F1CA6Q34063490-F9C78821-718C-4DF0-B867-84057A4C6C89Q34225808-193E9F58-3691-4CE4-989E-6AF1E20E13F2Q34452013-287D1AF9-FF0D-4FEF-83F4-F6FF7E5074E7Q34503911-F279AED2-69DB-4B10-BC2F-8E5DA35DFFA8Q34583258-6F139826-F67C-4E2F-AEE2-BF8FEAD89B7FQ34596901-1D8616A4-CA9E-40A4-811D-485CE21CFEDDQ34774541-A7D0C8C5-4F2D-4F1A-8936-B86E539BF247Q35106543-33ABBA72-ED42-443F-8A4B-1BA534001B8FQ35108652-36031753-065A-44C8-9B84-02A93BEB104DQ35282280-116F6113-6F02-40D8-8896-C2E62624BF82Q35300418-8F228462-BAB5-40E8-89BC-AAD8C9351ABDQ35551705-E5C3A4B0-FFC4-47B0-9E84-44AEEBC7167FQ35770325-78B06F89-4FD8-49C4-9CD3-0FFF51EB96DFQ35857382-9FA395B3-FE7E-4375-AFB6-2D94D4F65B59Q35880866-E01C2BD5-6A5C-4488-BC01-BC6A3F68748AQ36135527-2907A1F1-4107-4A29-B12D-1C709ECF2453Q36310789-BB200725-27CD-4AB5-B36B-E6EA694B0DBFQ36362670-4FA6AB0C-657E-419D-82D7-1A2A8DAE6C9EQ36363273-FFBA32CB-AA57-4AB0-903B-7C2FC67F3CACQ36364103-8468DDF3-82F8-4D03-B8D8-58EEC2137196Q36365676-40C5C3CC-DEA1-456F-A7E5-03A711164D4FQ36375095-31770B4B-2658-4D5E-BEEC-ACA5960CBDEDQ36464596-886C78EF-D23F-4C31-B59B-F6D63E04D3CBQ36470726-19FC151C-4FF0-4CE2-BCCA-82406C9334D8Q36470734-5D8ECA22-20FE-43AE-86A3-4BE943DF0A2FQ36478280-6CAED9D9-9011-41EC-BFA9-BE0FEFD140B7Q36617745-2A711C48-AE34-4BD2-BE89-8EE3FFF1FCDFQ36640998-F571E310-C5EA-463C-9168-EE273861BFE6Q36726974-3DEB06FD-18F1-4F37-B769-B97333B607C8Q36766511-AFD91B45-984D-4077-A5C3-505D2E1A4498Q36914397-2662AD91-6078-45D2-9008-928EB9BC286CQ36914404-26EE0EFC-ED00-47F7-94C3-E9B7650919BAQ36916513-8FEF6CDB-E56A-4DF1-99D2-4FECBC77840DQ36922798-3438FB1B-B7FB-4A96-A1C5-4D14429A3AAEQ36924466-532C053D-4F47-43E5-A19E-523DC4B11663Q37222679-C023D853-7887-4222-AEF6-1B9695A88B11Q37226687-6ACBFBF0-EE3B-4EE5-A1CD-0427151AE2F0
P2860
Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Lack of HLA class I antigen ex ...... defect in B2m gene expression
@en
type
label
Lack of HLA class I antigen ex ...... defect in B2m gene expression
@en
prefLabel
Lack of HLA class I antigen ex ...... defect in B2m gene expression
@en
P2093
P2860
P356
P1476
Lack of HLA class I antigen ex ...... defect in B2m gene expression
@en
P2093
P2860
P304
P356
10.1172/JCI114984
P407
P577
1991-01-01T00:00:00Z